Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,621,578
+$9,617,682 QoQ
Shares Held
6,065,661
+175.5% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$592,852
PutShares
87,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. RXRX ranks #109 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in RXRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,621,578 | 6,065,661 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,003,896 | 2,201,442 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $6,156,704 | 1,261,620 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,723,962 | 1,131,218 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,913,114 | 1,495,863 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $592,852 | 87,700 | Put | Defined | 2025-02-11 | |
| 2024-12-31 | $13,960,804 | 2,065,208 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $577,943 | 87,700 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $10,146,649 | 1,539,704 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,029,125 | 1,070,550 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,943,289 | 897,020 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,751,196 | 1,191,805 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $5,085,512 | 664,773 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,313,513 | 577,445 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $3,569,295 | 535,127 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,494,945 | 583,002 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,809,821 | 358,066 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,595,984 | 196,067 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,499,368 | 209,409 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,117,028 | 123,586 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $429,526 | 18,667 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $401,974 | 11,013 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||